Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self

Nature Immunology

Volumn 6, Issue 4, 2005, Pages 345-352

  Sakaguchi, Shimon ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; DNA BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR; LEUKOCYTE ANTIGEN;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELL FUNCTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; THYMUS; TRANSPLANTATION TOLERANCE; TUMOR IMMUNITY; ANIMAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NEOPLASM;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LYMPHOCYTE ACTIVATION; NEOPLASMS; RECEPTORS, INTERLEUKIN-2; SELF TOLERANCE; T-LYMPHOCYTES; THYMUS GLAND; TRANSPLANTATION IMMUNOLOGY;

EID: 16844365788     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1178     Document Type: Review

References (107)

1. Shevach, E.M. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18, 423-449 (2000).
2. Maloy, K.J. & Powrie, F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2, 816-822 (2001).
3. Coutinho, A. et al. Regulatory T cells: the physiology of autoreactivity in dominant tolerance and "quality control" of immune responses, Immunol. Rev. 182, 89-98 (2001).
4. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
5. Baecher-Allan, C. & Hafler, D.A. Suppressor T cells in human diseases. J. Exp. Med. 200, 273-276 (2004).
6. Sakaguchi, S. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
7. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
8. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
9. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
10. Sakaguchi, S., Fukuma, K., Kuribayashi, K. & Masuda, T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161, 72-87 (1985).
11. low subset. J. Exp. Med. 172, 1701-1708 (1990).
12. McKeever, U. et al. Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. Proc. Natl. Acad. Sci. USA 87, 7618-7622 (1990).
13. Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387-396 (1996).
14. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317-5326 (1999).
15. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212-1218 (1998).
16. Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190-200 (2001).
17. Fontenot, J.D. & Rudensky, A. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6, 331-337 (2005).
18. Gambineri, E., Torgerson, T.R. & Ochs, H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430-435 (2003).
19. Brunkow, M.E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73 (2001).
20. Chatila, T.A. et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75-R81 (2000).
21. Wildin, R.S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18-20 (2001).
22. Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 (2001).
23. Tommasini, A. et al. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin. Exp. Immunol. 130, 127-130 (2002).
24. Horak, I., Lohler, J., Ma, A. & Smith, K.A. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol. Rev. 148, 35-44 (1995).
25. Kramer, S., Schimpl, A. & Hunig, T. Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 182, 1769-1776 (1995).
26. Willerford, D.M. et al. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530 (1995).
27. Suzuki, H. et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268, 1472-1476 (1995).
28. Klebb, G. et al. Interleukin-2 is indispensable for development of immunological self-tolerance. Clin. Immunol. Immunopathol. 81, 282-286 (1996).
29. + T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31, 1637-1645 (2001).
30. + T cell numbers. J. Immunol. 169, 4850-4860 (2002).
31. Malek, T.R. et al. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167-178 (2002).
32. + T cells. Proc. Natl. Acad. Sci. USA 99, 8832-8837 (2002).
33. + regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
34. + regulatory T cell function. J. Exp. Med. 196, 851-857 (2002).
35. + T cell suppressor function. J. Immunol. 172, 6519-6523 (2004).
36. Chastagner, P. et al. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor α, β and γ chain expression for T cell growth. Eur. J. Immunol. 26, 201-206 (1996).
37. Nelson, B.H. & Willerford, D.M. Biology of the interleukin-2 receptor. Adv. Immunol. 70, 1-81 (1998).
38. Chen, Y. et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240 (1994).
39. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
40. + regulatory T cells. Int. Immunol. 16, 1189-1201 (2004).
41. + regulatory T cells. Int. Immunol. 16, 1643-1656 (2004).
42. - subpopulations. J. Immunol. 165, 3105-3110 (2000).
43. von Boehmer, H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338-344 (2005).
44. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440 (2000).
45. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
46. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310 (2000).
47. Bachmann, M.F. et al. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131 (1999).
48. + regulatory T cell function. Eur. J. Immunol. 34, 2996-3005 (2004).
49. + regulatory T cells. Eur. J. Immunol. 32, 2888-2896 (2002).
50. Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206-1212 (2003).
51. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100-4110 (2004).
52. Paust, S., Lu, L., McCarty, N. & Cantor, H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101, 10398-10403 (2004).
53. + regulatory T cells. J. Immunol. 171, 3348-3352 (2003).
54. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
55. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
56. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247 (2003).
57. + regulatory cell activation and function by dendritic cells. Int. Immunol. 16, 1769-1780 (2004).
58. Collins, A.V. et al. The interaction properties of costimulatory molecules revisited. Immunity 17, 201-210 (2002).
59. Zheng, Y. et al. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172, 2778-2784 (2004).
60. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3, 135-142 (2002).
61. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
62. Ronchetti, S., Nocentini, G., Riccardi, C. & Pandolfi, P.P. Role of GITR in activation response of T lymphocytes. Blood 100, 350-352 (2002).
63. + T cells. J. Immunol. 172, 7306-7314 (2004).
64. + T cells. J. Immunol. 173, 5008-5020 (2004).
65. Ji, H.B. et al. Cutting edge: the natural ligand for glucocorticoid- induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 172, 5823-5827 (2004).
66. Tone, M. et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100, 15059-15064 (2003).
67. Kumanogoh, A. et al. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J. Immunol. 166, 353-360 (2001).
68. + T cells. Immunity 19, 877-889 (2003).
69. Bour-Jordan, H. et al. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J. Clin. Invest. 114, 979-987 (2004).
70. + T cell-mediated suppression by dendritic cells. Science 299, 1033-1036 (2003).
71. Pasare, C. & Medzhitov, R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21, 733-741 (2004).
72. Caramalho, I. et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197, 403-411 (2003).
73. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194, 629-644 (2001).
74. + regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA 101, 4572-4577 (2004).
75. + T cells. J. Immunol. 173, 6526-6531 (2004).
76. Thompson, C. & Powrie, F. Regulatory T cells. Curr. Opin. Pharmacol. 4, 408-414 (2004).
77. + T cell receptors. Immunity 21, 267-277 (2004).
78. + regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 101, 15434-15439 (2004).
79. + T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc. Natl. Acad. Sci, USA 100, 10902-10906 (2003).
80. Klein, L., Khazaie, K. & von Boehmer, H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100, 8886-8891 (2003).
81. + regulatory T cells in vivo. J. Exp. Med. 198, 249-258 (2003).
82. + regulatory T cells in the steady state. J. Exp, Med. 198, 737-746 (2003).
83. Ginsberg-Fellner, F. et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev. Infect. Dis. 7, S170-S176 (1985).
84. + T-Cell production in healthy humans and in patients with thymic hypoplasia. Clin. Diagn. Lab. Immunol. 9, 1129-1131 (2002).
85. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511 (2003).
86. Encinas, J.A. et al. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing 112. Nat. Genet. 21, 158-160(1999).
87. Podolin, P.L. et al. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine 12, 477-482 (2000).
88. Tang, Q. et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455-1465 (2004).
89. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467-1477 (2004).
90. Bach, J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911-20 (2002).
91. Boon, T. et al. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12, 337-365 (1994).
92. Dunn, G.P., Old, L.J. & Schreiber, R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148 (2004).
93. + T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163, 5211-5218 (1999).
94. Onizuka, S. et al. Tumor rejection by in vitro administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res. 59, 3128-3133 (1999).
95. + regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194, 823-832 (2001).
96. + regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol. 32, 3267-3275 (2002).
97. Danke, N.A. et al. Autoreactive T cells in healthy individuals. J. Immunol. 172, 5967-5972 (2004).
98. Phan, G.Q. et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 100, 8372-8377 (2003).
99. high regulatory T cells. Blood 104, 895-903 (2004).
100. + T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104, 453-461 (2004).
101. Wood, K.J. & Sakaguchi, S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3, 199-210 (2003).
102. Waldmann, H. et al. Regulatory T cells and organ transplantation. Semin. Immunol. 16, 119-126 (2004).
103. Aluvihare, V.R., Kallikourdis, M. & Betz, A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266-271 (2004).
104. Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988 (1995).
105. Tivol, E.A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
106. Taguchi, O. & Takahashi, T. Administration of anti-interleukin-2 receptor α antibody in vivo induces localized autoimmune disease. Eur. J. Immunol. 26, 1608-1612 (1996).
107. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168, 5979-5983 (2002).